GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

FBK · Mar 31, 2026

FB Financial Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001649749-26-000040Bank
Sequential deposit growth55thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

1.20% · CORE · VALID

Net-income growth75thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

46.15% · CORE · VALID

Interest-income growth60thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

25.40% · CORE · VALID

Cash and equivalents55thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$1.2B · CORE · VALID

Sequential loan growth30thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

0.98% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History39 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
0.70%
Current
1.20%
Delta
0.50%
Earnings Growth Increased
Previous
5.68%
Current
46.15%
Delta
40.47%
Interest Income Growth Increased
Previous
14.94%
Current
25.40%
Delta
10.46%
Liquidity Increased
Previous
$1.2B
Current
$1.2B
Delta
$1.9M
Loan Growth Increased
Previous
0.70%
Current
0.98%
Delta
0.28%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.